Amyris: Out of the doghouse, but can the stock rally continue?
Amyris’ recovery from the doghouse of 2012 is nearly complete, but analysts are cautioning that the huge run-up in the share price may reflect some irrational exuberance. We investigate what’s up with the Barons of Biofene. If you are a devotee of the Biofuels Digest Index, you’ll note that yesterday it reached a 28-month high […]









